BATS BZX Real-Time Price
As of 3:58pm ET
| 0.00 / 0.00%|
The 4 analysts offering 12-month price forecasts for Neogenomics Inc have a median target of 7.00, with a high estimate of 8.00 and a low estimate of 7.00. The median estimate represents a +54.19% increase from the last price of 4.54.
The current consensus among 5 polled investment analysts is to Buy stock in Neogenomics Inc. This rating has held steady since February, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.